RKVTF
Rakovina Therapeutics Inc

71
Mkt Cap
$5.71M
Volume
10,200.00
52W High
$100.00
52W Low
$0.1812
PE Ratio
-0.44
RKVTF Fundamentals
Price
$0.19
Prev Close
$0.1944
Open
$0.1944
50D MA
$0.2921
Beta
0.00
Avg. Volume
14,022.76
EPS (Annual)
-$0.3602
P/B
1.67
Loading...
Loading...
Rakovina Therapeutics, Inc. focuses on the development of new cancer treatments based on novel DNA-damage response technologies. It engages in developing precision medicines that selectively target and kill cancer cells using science to discover and advance innovative cancer treatments with the potential to improve patient outcomes across multiple tumor types. The company was founded on May 6, 2019 and is headquartered in Vancouver, Canada.
Sector:
Finance
Industry:
Financial Conglomerates
Employees:
N/A

Frequently Asked Questions

What is Market Cap of Rakovina Therapeutics Inc?
What is the 52-week high for Rakovina Therapeutics Inc?
What is the 52-week low for Rakovina Therapeutics Inc?
What is Rakovina Therapeutics Inc stock price today?
What was Rakovina Therapeutics Inc stock price yesterday?
What is the PE ratio of Rakovina Therapeutics Inc?
What is the Price-to-Book ratio of Rakovina Therapeutics Inc?
What is the 50-day moving average of Rakovina Therapeutics Inc?

Latest RKVTF News

View
No RKVTF news at the moment.

Advertisement|Remove ads.

Advertisement|Remove ads.